The aim of this study was to compare the efficacy and safety of the essential oil-basedproduct in patients with mild to moderate symptomatic COVID-19 Positive infectionconfirmed by PCR. A computational simulation approach of the molecular interaction(binding) of the main components of essential oils exhibiting antiviral activity withknown intracellular protein targets of SARS-CoV-2 (nsp5: Main Protease) was adopted as arationale for this study. SARS-CoV-2, a single-stranded RNA virus, has four majorstructural proteins Spike (S), Membrane (M), Envelope glycoprotein (E) and Nucleocapsid(N) protein and non-structural proteins (nsp). These non-structural proteins, of whichthere are 16 in total in the genome of the virus, play key roles in the mechanisms of thevirus life cycle, including replication, transcription, protein synthesis andmodification of RNA. Main protease (Main protease, Mpro, 3CLpro), virus Since they aredirectly involved in the maturation of these nsp proteins, which have an important rolein many mechanisms of the life cycle, they have been the target enzyme in the developmentof new antiviral drugs for the treatment of COVID-19. In this study, our main rationaleis to investigate the effect of essential oils on nsp5: Main Protease enzyme activations.
The indiscriminate use of antimicrobial agents has led to the emergence of a number of
drug-resistant bacteria, fungi and viruses. To overcome the increasing resistance of
pathogenic microbes, more effective antimicrobial agents with new modes of action must be
developed.
Medicinal plants used in traditional medicines to treat infectious diseases are an
abundant source of new bioactive secondary metabolites. Therefore, in the last few years,
various medicinal plants and plant extracts have been screened for their antimicrobial
activities . Essential oils obtained from aromatic medicinal plants (e.g. fennel
(Foeniculum vulgare), mint (Mentha piperita), thyme (Thymus vulgaris)) have been shown to
have antimicrobial activity against gram-positive and gram-negative bacteria as well as
yeasts, It has been reported to be active against fungi and viruses. They are mixtures of
different lipophilic and volatile substances such as monoterpenes, sesquiterpenes and/or
phenylpropanoids and have a pleasant odour. They are also part of the pre-formed defence
system of higher plants are thought to be . Monoterpenes have been widely studied,
especially for their antiviral properties.
Nowadays, the use of essential oils is becoming increasingly widespread both in
pharmacies and in various stores. The use of essential oils for therapeutic purposes is
expanding. The molecules that make up certain essential oils have shown various antiviral
properties:
- Either by neutralising the virus before it enters the cell,
- By changing the capsid or envelope of the virus,
- Either by binding to receptors used by viruses and preventing their access to cells.
Herbal products are an important source of herbal remedies and other medicines. Essential
oils have shown various pharmacological activities, such as antiviral activity, and have
therefore been implicated in SARS-CoV- It has been suggested to have potential activity
against 2. Essential oils can easily penetrate the viral membrane due to their
lipophilicity and can cause rupture of the viral membrane.
In addition, crude essential oils often have many active components that can act on
different parts of the virus, including cell entry, translation, transcription and
assembly. Anti-inflammatory, immune regulation on the respiratory system of the host,
have other beneficial pharmacological effects, including bronchiectasis and mucolytics.
Essential oils have many advantages because they promise volatile antiviral molecules,
making them useful either alone or in combination with other chemotherapeutic drugs,
making them potential drug targets for the prevention and treatment of COVID-19.
In this study, a computational simulation approach of the molecular interaction (binding)
of the main components of essential oils exhibiting antiviral activity with known
intracellular protein targets of SARS-CoV-2 (nsp5: Master Protease) was adopted as a
rationale. A single-chain.
The RNA virus SARS-CoV-2 has four main structural proteins Spike (S), Membrane (M),
Envelope glycoprotein (E) and Nucleoapsid (N) proteins and non-structural proteins (nsp)
.
These non-structural proteins, of which there are 16 in total in the genome of the virus,
play a key role in the mechanisms of the virus life cycle, including replication,
transcription, protein synthesis and modification of RNA. Main protease (Mpro, 3CLpro)
has been the target enzyme for the development of new antiviral drugs for the treatment
of COVID-19 , as they are directly involved in the maturation of these nsp proteins,
which have an important role in many mechanisms of the virus life cycle. Our main
rationale in this study is to investigate the effect of essential oils on nsp5: Main
Protease enzyme activations.
Other: IMMUNO19
280 participants will be divided into 2 groups. There will be 140 participants in the
groups.
The 1st group will receive IMMUNO19 10 mL one time, The 2nd group will receive Placebo 10
mL for one time.
Other Name: Essential Oils Combination
Inclusion Criteria:
- Patients must be between 18 - The participant must be willing and able to give written informed consent. The - PCR test COVID-19 positive diagnosis and mild to moderate disease stage is required. - The participant must agree not to receive vaccines administered for COVID-19 during Exclusion Criteria: - Patients < 18 years of age, - Positive diagnosis of severe COVID-19 with symptoms of basic severity: patients with - Patients on active antiviral therapy, - Patients with creatine clearance < 30 ml/min and renal impairment, - NYHA III-IV, Stage D heart failure patients requiring frequent hospitalization, - Uncontrolled coagulopathy, - Patients with advanced liver failure, - Patients with active infections such as hepatitis B, hepatitis C and HIV, diseases - Patients with active malignancy and known history of cancer, - Those who do not have sufficient psychic state to disrupt working rounds, - Active drug users, - Known hypersensitivity and allergic reaction to the components of the preparation, - Current participation in another interventional treatment study with an - Recent use of the investigational product within 28 days of the first dose of the - Pregnant or breastfeeding women, - Patients who did not give written informed consent.
volunteer must provide his/her consent on his or her behalf, a legally acceptable
representative (i.e., an International Harmonization Council [ICH] and adopted by
local law as appropriate can be used) must give informed consent on his/her behalf.
the study.
respiratory distress, signs of mental confusion and impaired consciousness that
develop depending on the severity of the stage of the disease,
requiring systemic treatment,
investigational agent,
investigational product use or presence of a research device during screening,
Bağcılar Training and Research Hospital
Istanbul, Bagcılar, Turkey
Gaziosmanpaşa Training and Research Hospital
Istanbul, Gaziosmanpaşa, Turkey
Kocaeli City Hospital
Kocaeli, İzmit, Turkey
Göztepe Süleyman Yalçın City Hospital
Istanbul, Kadıköy, Turkey
Kartal Dr. Lütfi Kırdar City Hospital
Istanbul, Kartal, Turkey
Akdeniz University
Antalya, Konyaaltı, Turkey
Süreyyapaşa Chest Disease and Thoracic Surgery Training and Research Hospital
Istanbul, Maltepe, Turkey
Umraniye Training and Research Hospital
Istanbul, Umraniye, Turkey
Antalya Atatürk Public Hospital
Antalya, Turkey
Cemil Taşcıoğlu City Hospital
Istanbul, Şişli, Turkey
Mounir Bezzarga
+216 98 362260
mounir.bezzarga@yahoo.fr
İklim Turkoz
+90 543 259 59 40
iklim.turkoz@gamacro.com
Kanat Tayfun, MD, Principal Investigator
Bagcilar Training and Research Hospital